WuXi AppTec Co., Ltd. (FRA:WX8)

Market Cap	33.31B
Revenue (ttm)	5.25B
Net Income (ttm)	1.79B
Shares Out	n/a
EPS (ttm)	0.56
PE Ratio	18.56
Forward PE	18.07
Dividend	0.21 (1.79%)
Ex-Dividend Date	Sep 8, 2025

Volume	234
Average Volume	18
Open	11.70
Previous Close	11.90
Day's Range	11.50 - 11.70
52-Week Range	5.30 - 13.80
Beta	n/a
RSI	48.36
Earnings Date	Mar 15, 2026

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecula...

• Industry: Commercial Physical and Biological Research
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: WX8

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY